HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Linda Pestreich Selected Research

Fingolimod Hydrochloride (FTY720)

9/2014Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.
7/2013Randomized, open-label study to evaluate patient-reported outcomes with fingolimod after changing from prior disease-modifying therapy for relapsing multiple sclerosis: EPOC study rationale and design.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Linda Pestreich Research Topics

Disease

7Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
07/2013 - 01/2003
3Schizophrenia (Dementia Praecox)
01/2016 - 09/2012
2Multiple Sclerosis
09/2014 - 07/2013
2Fatigue
09/2014 - 07/2013
1Headache (Headaches)
09/2014
1Infections
09/2014

Drug/Important Bio-Agent (IBA)

6Dexmethylphenidate HydrochlorideFDA LinkGeneric
07/2013 - 06/2006
2Aripiprazole (Abilify)FDA Link
01/2016 - 03/2014
2Fingolimod Hydrochloride (FTY720)FDA Link
09/2014 - 07/2013
2Methylphenidate (Ritalin)FDA LinkGeneric
07/2013 - 01/2003
1TabletsIBA
01/2016
1Risperidone (Risperdal Consta)FDA LinkGeneric
03/2014
1Olanzapine (Zyprexa)FDA Link
03/2014
1iloperidoneFDA Link
03/2014
1Antipsychotic Agents (Antipsychotics)IBA
09/2012

Therapy/Procedure

3Therapeutics
09/2014 - 07/2013
1Injections
09/2014
1Immunomodulation
09/2014
1Activities of Daily Living (ADL)
07/2013